Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00045654.xml
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2015; 05(02): 004-007
DOI: 10.1055/s-0040-1703879
DOI: 10.1055/s-0040-1703879
Original Article
GENTAMICIN: MYTHS AND TRUTHS
Abstract
Gentamicin belongs to the group of antimicrobial agents, aminoglycosides. It is the prototype member of this group of antimicrobial agents that is utilized to treat various bacterial infections, mostly those caused by Gram negative bacteria. This is due to its irreversible binding to the 30S component of the ribosome. But the use of aminoglycosides and thus Gentamicin is limited owing to its profound adverse effects on the ear & the kidney. But proper calculation of the dosage can limit these side effects and prove to be an effective antimicrobial agent.
Publication History
Article published online:
22 April 2020
© .
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Alfred Goodman Gilman, Theodore Rall, Alan Nies, Palmer Taylor. Goodman & Gilman's The Pharmacological basis of Therapeutics. 8th Ed. Volume II. Maxwell Macmillan International Editions.
- 2 K. D. Tripathi. Essentials of Medical Pharmacology. 5th ed. Jaypee brothers Medical publishers Pvt Ltd.
- 3 C.R.W. Edwards, I.A.D. Bouchier, C. Haslett. Davidson's principles and th Practice of Medicine. 17 Ed. ELBS with Churchill Livingstone.
- 4 A. Abdel-Bari, M. Sherif Mokhtar, Nagwa Ali Sabry, Sanaa Abd El-Shafi, Naglaa Samir Bazan. Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients. Saudi Pharmaceutical Journal (2011) 19, 9–17.